Canine mammary carcinoma: an update.

CMC is the most common tumor in unspayed dogs and shares important features with human breast cancer.

Canine mammary carcinoma (CMC) represents the most common tumor diagnosis in intact female dogs and constitutes a leading cause of canine mortality, making it clinically significant in veterinary practice. This comprehensive review synthesizes current knowledge on CMC, encompassing clinical presentation and diagnostic methodologies, histopathological classification, and clinicopathological correlations. The article examines epidemiological patterns and carcinogenic mechanisms underlying tumor development, including metabolic reprogramming characteristic of malignant transformation. Therapeutic interventions and management strategies are evaluated alongside discussion of relevant biomarkers. Additionally, prognostic and predictive factors influencing clinical outcomes are addressed. The review emphasizes CMC's value as a spontaneous animal biomodel for human breast cancer research, given substantial biological and clinical parallels between canine and human disease. This comparative oncology perspective facilitates translational research opportunities while advancing understanding of both veterinary and human mammary malignancies.

This summary was distilled by AI and may occasionally misinterpret data. Confirm critical details with the primary literature before clinical application.